paclitaxel has been researched along with avermectin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Huisman, MT; Schinkel, AH; Smit, JW; van Tellingen, O; Wiltshire, HR | 1 |
Drinyaev, VA; Ermakova, NV; Korystov, YN; Kruglyak, EB; Kublik, LN; Levitman, MKh; Mosin, VA; Novik, TS; Shaposhnikova, VV; Sterlina, TS | 1 |
2 other study(ies) available for paclitaxel and avermectin
Article | Year |
---|---|
Absence or pharmacological blocking of placental P-glycoprotein profoundly increases fetal drug exposure.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carbon Radioisotopes; Crosses, Genetic; Digoxin; Female; Heterozygote; Insecticides; Ivermectin; Male; Maternal-Fetal Exchange; Mice; Mice, Knockout; Mice, Mutant Strains; Paclitaxel; Placenta; Pregnancy; Saquinavir; Tissue Distribution | 1999 |
Avermectins inhibit multidrug resistance of tumor cells.
Topics: Animals; Cell Division; Cell Line, Tumor; Cell Survival; Cyclosporine; Dose-Response Relationship, Drug; Drug Combinations; Drug Evaluation, Preclinical; Drug Resistance, Multiple; Drug Synergism; Fluoresceins; Fluorescence; Humans; Ivermectin; Leukemia P388; Male; Mice; Paclitaxel; Rhodamine 123; Russia; Vincristine | 2004 |